NOTE 7: EQUITY
On June 11, 2021, the Company issued one billion one hundred million (1,100,000,000) of restricted shares of
common stock to Dr. David Dalton as his conversion of $11,000 on the Company’s debt of Accrued employees
benefits deducted on January 3, 2016, dated on which was that conversion submitted to the transfer agent.
On March 1, 2022, Dr. David Dalton converted $41,451.30 of the Company debt due to Accrued employees’ benefits
from prior periods into 1,256,100 preferred shares par value $0.001 at $0.033 per shares.
On August 30, 2022, Dr. David Dalton converted $1,740,145 total employment contract benefits for prior periods.
The 183,173,158 fully paid and nonassessable shares for this conversion were valued at 110% of the stock price
ending 08/30/2022 $0.0095.
100 Million of them added to the DTC
PL
On June 11, 2021, the Company issued one billion one hundred million (1,100,000,000) of restricted shares of
common stock to Dr. David Dalton as his conversion of $11,000 on the Company’s debt of Accrued employees
benefits deducted on January 3, 2016, dated on which was that conversion submitted to the transfer agent.
On March 1, 2022, Dr. David Dalton converted $41,451.30 of the Company debt due to Accrued employees’ benefits
from prior periods into 1,256,100 preferred shares par value $0.001 at $0.033 per shares.
On August 30, 2022, Dr. David Dalton converted $1,740,145 total employment contract benefits for prior periods.
The 183,173,158 fully paid and nonassessable shares for this conversion were valued at 110% of the stock price
ending 08/30/2022 $0.0095.
100 Million of them added to the DTC
PL
1
